BioAtla (BCAB) Equity Ratio (2020 - 2025)
BioAtla (BCAB) has disclosed Equity Ratio for 6 consecutive years, with 2.62 as the latest value for Q4 2025.
- For Q4 2025, Equity Ratio rose 861.74% year-over-year to 2.62; the TTM value through Dec 2025 reached 2.62, up 861.74%, while the annual FY2025 figure was 2.62, 861.74% up from the prior year.
- Equity Ratio hit 2.62 in Q4 2025 for BioAtla, up from 1.96 in the prior quarter.
- Across five years, Equity Ratio topped out at 2.62 in Q4 2025 and bottomed at 1.96 in Q3 2025.
- Average Equity Ratio over 5 years is 0.54, with a median of 0.72 recorded in 2023.
- On a YoY basis, Equity Ratio climbed as much as 861.74% in 2025 and fell as far as 632.07% in 2025.
- BioAtla's Equity Ratio stood at 0.83 in 2021, then fell by 3.59% to 0.8 in 2022, then decreased by 26.07% to 0.59 in 2023, then crashed by 53.93% to 0.27 in 2024, then skyrocketed by 861.74% to 2.62 in 2025.
- According to Business Quant data, Equity Ratio over the past three periods came in at 2.62, 1.96, and 0.62 for Q4 2025, Q3 2025, and Q2 2025 respectively.